SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: wlheatmoon who wrote (44368)1/22/1999 6:40:00 PM
From: RealMuLan  Read Replies (3) | Respond to of 132070
 
Maybe you can check out Supergen (SUPG). Today it is up over 11%. They have a cancer drug expected for FDA approval in June or Dec.? I don't have position right now, but played it a couple of days ago. It is a good buy around $10. It really moves on a relatively low volume.



To: wlheatmoon who wrote (44368)1/23/1999 1:47:00 PM
From: Knighty Tin  Read Replies (1) | Respond to of 132070
 
Mike, Yup, I have owned Vical in the past and it has made my money smile. I love this area of biotech, even though I think Vical will be bought a bit cheaper later on.

I like Incyte under $25, preferably around $22. I tend to sell it in the mid 30s. It has worked like a charm this year several times. A truly great co. that goes from worry to overconfidence on the herds' investment radar.

MB



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News